/Investor DB

Mizuho Capital — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

PRD Therapeuticsprdtherapeutics.comSep 2023

PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism.

BiotechLongevityTokyo, JP

細田 莞爾(代表取締役社長 / President & Co-Founder)供田 洋(社外取締役 / Co-Founder)

Co-investorsJIC Venture Growth InvestmentsJAFCO GroupSMBC Venture Capital

アソビューasoview.co.jpJul 2023

Japanese operator of the asoview! leisure-activity booking marketplace and DX/SaaS ticketing solutions for tourism and leisure facilities.

Co-investorsGlobal BrainGlobis Capital PartnersKiraboshi CapitalRegional Revitalization SolutionSBI Shinsei Corporate InvestmentJAFCO Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.